Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients.
from Cancer via ola Kala on Inoreader http://ift.tt/1O9yV9B
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου